Ifrah Financial Services’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,504
| Closed | -$205K | – | 208 |
|
|
2023
Q3 | $205K | Buy |
3,504
+30
| +0.9% | +$1.88K | 0.06% | 192 |
|
|
2023
Q2 | $219K | Buy |
3,474
+106
| +3% | +$6.75K | 0.07% | 192 |
|
|
2023
Q1 | $212K | Buy |
+3,368
| New | +$201K | 0.07% | 195 |
|
|
2022
Q3 | – | Sell |
-3,525
| Closed | -$255K | – | 203 |
|
|
2022
Q2 | $255K | Sell |
3,525
-60
| -2% | -$4.47K | 0.08% | 167 |
|
|
2022
Q1 | $285K | Sell |
3,585
-6
| -0.2% | -$541 | 0.08% | 172 |
|
|
2021
Q4 | $363K | Sell |
3,591
-12
| -0.3% | -$1.2K | 0.1% | 150 |
|
|
2021
Q3 | $332K | Buy |
3,603
+96
| +3% | +$9.24K | 0.1% | 150 |
|
|
2021
Q2 | $359K | Buy |
3,507
+91
| +3% | +$9.14K | 0.1% | 149 |
|
|
2021
Q1 | $333K | Sell |
3,416
-29
| -0.8% | -$2.64K | 0.1% | 152 |
|
|
2020
Q4 | $266K | Sell |
3,445
-891
| -21% | -$68.9K | 0.09% | 161 |
|
|
2020
Q3 | $319K | Buy |
4,336
+213
| +5% | +$17.1K | 0.11% | 134 |
|
|
2020
Q2 | $303K | Buy |
4,123
+157
| +4% | +$12.3K | 0.11% | 141 |
|
|
2020
Q1 | $229K | Buy |
3,966
+45
| +1% | +$3.13K | 0.1% | 144 |
|
|
2019
Q4 | $308K | Sell |
3,921
-118
| -3% | -$8.69K | 0.11% | 140 |
|
|
2019
Q3 | $276K | Sell |
4,039
-697
| -15% | -$46.8K | 0.1% | 141 |
|
|
2019
Q2 | $376K | Buy |
4,736
+155
| +3% | +$12.3K | 0.14% | 125 |
|
|
2019
Q1 | $384K | Buy |
4,581
+201
| +5% | +$21K | 0.15% | 123 |
|
|
2018
Q4 | $516K | Sell |
4,380
-131
| -3% | -$15.1K | 0.22% | 87 |
|
|
2018
Q3 | $544K | Sell |
4,511
-34
| -0.7% | -$4.22K | 0.19% | 102 |
|
|
2018
Q2 | $524K | Buy |
4,545
+30
| +0.7% | +$3.28K | 0.19% | 100 |
|
|
2018
Q1 | $388K | Buy |
4,515
+766
| +20% | +$59.3K | 0.14% | 134 |
|
|
2017
Q4 | $278K | Buy |
+3,749
| New | +$251K | 0.1% | 160 |
|
|
2017
Q3 | – | Sell |
-3,481
| Closed | -$223K | – | 208 |
|
|
2017
Q2 | $223K | Sell |
3,481
-105
| -3% | -$6.47K | 0.09% | 172 |
|
|
2017
Q1 | $207K | Sell |
3,586
-1,516
| -30% | -$90.5K | 0.08% | 176 |
|
|
2016
Q4 | $312K | Sell |
5,102
-188
| -4% | -$12.2K | 0.13% | 148 |
|
|
2016
Q3 | $366K | Buy |
5,290
+444
| +9% | +$29.3K | 0.15% | 129 |
|
|
2016
Q2 | $270K | Sell |
4,846
-3,186
| -40% | -$192K | 0.11% | 151 |
|
|
2016
Q1 | $488K | Sell |
8,032
-274
| -3% | -$16.1K | 0.19% | 89 |
|
|
2015
Q4 | $531K | Sell |
8,306
-54
| -0.6% | -$3.5K | 0.21% | 92 |
|
|
2015
Q3 | $560K | Sell |
8,360
-42
| -0.5% | -$2.97K | 0.23% | 85 |
|
|
2015
Q2 | $574K | Sell |
8,402
-148
| -2% | -$9.39K | 0.21% | 90 |
|
|
2015
Q1 | $475K | Sell |
8,550
-30
| -0.3% | -$1.54K | 0.18% | 102 |
|
|
2014
Q4 | $440K | Sell |
8,580
-502
| -6% | -$24.6K | 0.17% | 107 |
|
|
2014
Q3 | $334K | Sell |
9,082
-96
| -1% | -$3.46K | 0.13% | 132 |
|
|
2014
Q2 | $359K | Buy |
+9,178
| New | +$341K | 0.14% | 126 |
|
Other funds holding USNA
Ifrah Financial Services's USNA Position: Q4 2023 in Review
Ifrah Financial Services sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 3,504 shares — an estimated $205K sold.
Ifrah Financial Services first reported a position in USNA in Q2 2014 and held it in 35 quarters. The position peaked at $574K in Q2 2015. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.
- Ifrah Financial Services reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
- Ifrah Financial Services sold 3,504 Usana Health Sciences shares in Q4 2023, an estimated $205K.
- Ifrah Financial Services first reported a position in Usana Health Sciences in Q2 2014 and held it in 35 quarters.
- Ifrah Financial Services's Usana Health Sciences position peaked at $574K in Q2 2015.
- 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.
Based on Ifrah Financial Services's 13F filing for Q4 2023, filed 6 Feb 2024.